Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yahom-Navakot remedy plus levofloxacin vs levofloxacin alone for prevention of nosocomial infection in post–cardiac arrest patients undergoing targeted temperature management
TCTR20200430004Phase 4Unknown
- Sponsor
- Thammasat University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Healthcare-associated infection (HAI), sponsored by Thammasat University. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
Healthcare-associated infection (HAI)
Beyond the preview
Go deeper on TCTR20200430004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200430004.